What does a Hounsfield unit (HU) value of 9 indicate in an adrenal mass?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hounsfield Units in Adrenal Masses: Diagnostic Significance of 9 HU

A Hounsfield unit (HU) value of 9 in an adrenal mass strongly suggests a benign adrenal adenoma, as it falls below the critical threshold of 10 HU that distinguishes benign from potentially malignant lesions. 1

Diagnostic Significance of Hounsfield Units in Adrenal Masses

Hounsfield units are a standardized quantitative measurement of tissue density on non-contrast CT imaging. For adrenal masses, the HU value provides crucial information about the internal composition of the lesion:

  • <10 HU: Strongly indicates a benign lipid-rich adenoma with 100% specificity 2
  • 10-20 HU: Indeterminate range requiring additional evaluation
  • >20 HU: Higher risk of malignancy, particularly if >4 cm or heterogeneous

Why 9 HU Indicates Benignity

At 9 HU, an adrenal mass demonstrates the following characteristics:

  • Falls below the established 10 HU threshold used to identify lipid-rich adenomas 1, 3
  • Has virtually 0% risk of being adrenocortical carcinoma when homogeneous with smooth borders 3, 2
  • Contains sufficient intracytoplasmic lipid, a hallmark of benign adrenocortical adenomas 1

Clinical Implications of a 9 HU Adrenal Mass

The finding of 9 HU in an adrenal mass has significant implications for patient management:

  1. Low Malignancy Risk: A homogeneous mass with 9 HU has extremely low risk of malignancy 2

  2. Follow-up Recommendations:

    • If <4 cm and clearly benign appearing (as indicated by 9 HU), no further imaging follow-up is typically required 3
    • For masses ≥4 cm despite benign density, consider follow-up imaging in 6-12 months 3
  3. Hormonal Evaluation:

    • Despite benign imaging characteristics, hormonal evaluation remains essential as 12-23% of incidentalomas demonstrate subclinical hormone production 3
    • Testing should include 1-mg overnight dexamethasone suppression test, plasma/urinary metanephrines, and aldosterone-to-renin ratio if hypertensive 3

Diagnostic Algorithm for Adrenal Masses Based on HU Values

  1. <10 HU (including 9 HU):

    • Diagnosis: Benign adrenal adenoma
    • Action: Complete hormonal evaluation; no further imaging needed if <4 cm and homogeneous
  2. 10-20 HU:

    • Diagnosis: Indeterminate
    • Action: Consider delayed contrast washout CT (>60% washout at 15 minutes suggests benign) or chemical shift MRI 1
  3. >20 HU:

    • Diagnosis: Suspicious for malignancy, especially if >4 cm
    • Action: Surgical consultation for potential adrenalectomy 3

Important Caveats and Pitfalls

  • CT Scanner Variability: There can be some variability in density measurements between different CT scanners 1

  • Heterogeneity Matters: Even with a mean HU value of 9, heterogeneous appearance or irregular margins should raise suspicion 1

  • Size Consideration: While 9 HU strongly suggests benignity, larger masses (>4-6 cm) may warrant surgical consideration despite benign density characteristics 3, 4

  • Histographic Analysis: For borderline cases, analyzing the histogram of pixel values can improve diagnostic accuracy—if ≥5% of pixels are <0 HU, the lesion is likely benign 1

In conclusion, an adrenal mass with 9 HU represents a lipid-rich adenoma with extremely high probability, allowing clinicians to confidently classify it as benign from an imaging perspective, though hormonal evaluation remains necessary to rule out subclinical hormone production.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adrenal Masses Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adrenal tumors: how to establish malignancy ?

Journal of endocrinological investigation, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.